These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 348069)

  • 21. Inhibition of the sympathetic nervous system by dopamine.
    Ilhan M; Long JP
    Arch Int Pharmacodyn Ther; 1975 Jul; 216(1):4-10. PubMed ID: 1164103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
    Enjalbert A; Bockaert J
    Mol Pharmacol; 1983 May; 23(3):576-84. PubMed ID: 6306429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system.
    Spano PF; Govoni S; Trabucchi M
    Adv Biochem Psychopharmacol; 1978; 19():155-65. PubMed ID: 358777
    [No Abstract]   [Full Text] [Related]  

  • 24. Neural regulation of cutaneous circulation.
    Abramson DI
    Adv Biol Skin; 1972; 12():207-33. PubMed ID: 4579194
    [No Abstract]   [Full Text] [Related]  

  • 25. Uptake of nicotine by the sympathetic nerve terminals in the blood vessel.
    Bevan JA; Su C
    J Pharmacol Exp Ther; 1972 Sep; 182(3):419-26. PubMed ID: 5055404
    [No Abstract]   [Full Text] [Related]  

  • 26. No evidence for increased dopamine receptor binding in superresponsive mice after a single dose of neuroleptics.
    Hyttel J
    Adv Biochem Psychopharmacol; 1980; 24():167-73. PubMed ID: 6105773
    [No Abstract]   [Full Text] [Related]  

  • 27. Differential modification of striatal D1 dopamine receptors and effector moieties by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo and in vitro.
    Hess EJ; Battaglia G; Norman AB; Creese I
    Mol Pharmacol; 1987 Jan; 31(1):50-7. PubMed ID: 3100940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine-sensitive adenylate cyclase and receptor binding activities after acute and chronic neuroleptic drug treatment.
    Clement-Cormier Y
    Adv Biochem Psychopharmacol; 1980; 24():103-11. PubMed ID: 6105768
    [No Abstract]   [Full Text] [Related]  

  • 29. Evidence for a widely distributed peripheral dopaminergic system.
    Lacković Z; Relja M
    Fed Proc; 1983 Oct; 42(13):3000-4. PubMed ID: 6137419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repeated amphetamine pretreatment alters the responsiveness of striatal dopamine-stimulated adenylate cyclase to amphetamine-induced desensitization.
    Barnett JV; Segal DS; Kuczenski R
    J Pharmacol Exp Ther; 1987 Jul; 242(1):40-7. PubMed ID: 2956412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The mechanism of hyperemia developing after introduction of fluid into the submaxillary gland].
    Andronov VA; Khaiutin VM
    Fiziol Zh SSSR Im I M Sechenova; 1974 Oct; 60(10):1573-81. PubMed ID: 4448218
    [No Abstract]   [Full Text] [Related]  

  • 33. Retrograde axonal transport of horseradish peroxidase in peripheral autonomic nerves.
    Ellison JP; Clark MG
    J Comp Neurol; 1975 May; 161(1):103-13. PubMed ID: 48519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the activation of adenylate cyclase from the submaxillary gland and pancreas.
    Bhoola KD; Lemon MJ
    J Physiol; 1973 Jul; 232(2):83P-84P. PubMed ID: 4727108
    [No Abstract]   [Full Text] [Related]  

  • 35. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat.
    Alkadhi KA; Sabouni MH; Ansari AF; Lokhandwala MF
    J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine is an important neurotransmitter in the autonomic nervous system.
    Thorner MO
    Lancet; 1975 Mar; 1(7908):662-5. PubMed ID: 47084
    [No Abstract]   [Full Text] [Related]  

  • 37. Hyperpolarization in hamster submandibular ganglion cell mediated by dopamine D2 receptors.
    Suzuki T
    Bull Tokyo Dent Coll; 1992 Feb; 33(1):29-32. PubMed ID: 1423812
    [No Abstract]   [Full Text] [Related]  

  • 38. Morphological characteristics of the ontogenesis of the mammalian peripheral adrenergic nervous system with special remarks on the human fetus.
    Kanerva L; Hervonen A; Hervonen H
    Med Biol; 1974 Jun; 52(3):144-53. PubMed ID: 4608251
    [No Abstract]   [Full Text] [Related]  

  • 39. Ergot drugs and central monoaminergic mechanisms: a histochemical, biochemical and behavioral analysis.
    Fuxe K; Fredholm BB; Ogren SO; Agnati LF; Hökfelt T; Gustafsson JA
    Fed Proc; 1978 Jun; 37(8):2181-91. PubMed ID: 350633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The autonomic nervous system.
    Hall JL; Humbertson AO
    Prog Neurol Psychiatry; 1968; 23():253-70. PubMed ID: 4887424
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.